1. Home
  2. DUOL vs XENE Comparison

DUOL vs XENE Comparison

Compare DUOL & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Duolingo Inc.

DUOL

Duolingo Inc.

HOLD

Current Price

$130.16

Market Cap

6.3B

Sector

Technology

ML Signal

HOLD

XENE

Xenon Pharmaceuticals Inc.

HOLD

Current Price

$62.36

Market Cap

5.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DUOL
XENE
Founded
2011
1996
Country
United States
Canada
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
5.2B
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
DUOL
XENE
Price
$130.16
$62.36
Analyst Decision
Buy
Strong Buy
Analyst Count
18
11
Target Price
$176.69
$68.55
AVG Volume (30 Days)
1.3M
596.0K
Earning Date
05-04-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
355.85
N/A
EPS
1.53
N/A
Revenue
$1,037,589,000.00
$311,000.00
Revenue This Year
$18.93
N/A
Revenue Next Year
$14.02
$2,496.48
P/E Ratio
$86.82
N/A
Revenue Growth
38.71
N/A
52 Week Low
$87.89
$35.60
52 Week High
$368.39
$72.66

Technical Indicators

Market Signals
Indicator
DUOL
XENE
Relative Strength Index (RSI) 48.23 45.75
Support Level $96.82 $61.16
Resistance Level $138.41 $62.91
Average True Range (ATR) 8.52 2.06
MACD -0.51 -0.43
Stochastic Oscillator 48.84 23.19

Price Performance

Historical Comparison
DUOL
XENE

About DUOL Duolingo Inc.

Duolingo Inc is a technology company that develops a mobile learning platform to learn languages. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated, master new material, and achieve their learning goals. Its solutions include the Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has four predominant sources of revenue: time-based subscriptions, in-app advertising placement by third parties, the Duolingo English Test, and In-App purchases. Geographically, the company generates revenue from its customers in the United States and other markets.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Share on Social Networks: